Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ImmunoGen Company Profile (NASDAQ:IMGN)

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $16.80 (90.05% upside)

Analysts' Ratings History for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/25/2014Morgan StanleyInitiated CoverageUnderweight$10.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2014Canaccord GenuityInitiated CoverageBuy -> Buy$20.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014GuggenheimBoost Price Target$14.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Morgan StanleyDowngradeEqual Weight -> Underweight$9.50ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013RBC CapitalLower Price TargetOutperform$22.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Chardan CapitalReiterated RatingBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013GuggenheimLower Price TargetNeutral$17.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Stifel NicolausDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Chardan CapitalInitiated CoverageBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
9/9/2013Jefferies GroupReiterated RatingPositive -> Buy$21.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2013Leerink SwannInitiated CoverageOutperform$24.00ViewTweet This Rating  Share This Rating on StockTwits
8/26/2013Roth CapitalInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2013Credit SuisseBoost Price TargetNeutral$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013RBC CapitalBoost Price TargetOutperform$17.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013GuggenheimBoost Price TargetNeutral$14.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013Cantor FitzgeraldBoost Price TargetHold$13.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013Cowen and CompanyReiterated RatingOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Cantor FitzgeraldBoost Price TargetHold$12.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2013Jefferies GroupBoost Price TargetBuy$17.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Jefferies GroupReiterated RatingBuy$16.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013OppenheimerDowngradeOutperform -> Market Perform$14.00ViewTweet This Rating  Share This Rating on StockTwits
12/6/2012Morgan StanleyInitiated CoverageEqual WeightViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Credit SuisseInitiated CoverageNeutral$12.00ViewTweet This Rating  Share This Rating on StockTwits
11/9/2012GuggenheimInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
10/29/2012Cantor FitzgeraldLower Price TargetHold$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/21/2012 forward)
Discuss ImmunoGen